SELLAS Life Sciences Group, Inc. (SLS) Tops Q2 EPS by 1c

SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) reported Q2 EPS of ($0.07), $0.01 better than the analyst estimate of ($0.08).

For earnings history and earnings-related data on SELLAS Life Sciences Group, Inc. (SLS) click here.

You May Also Be Interested In

• Corporación América Airports S.A. (CAAP) Misses Q2 EPS by 18c
• Klarna shares tumble on weak full-year revenue guidance
• JPMorgan Downgrades Reliance Worldwide Corp Ltd (RWC:AU) (RLLWF) to Neutral